Logo image of REE

REE AUTOMOTIVE LTD - CLASS A (REE) Stock Fundamental Analysis

NASDAQ:REE - Nasdaq - IL0011786154 - Common Stock - Currency: USD

0.7801  +0.03 (+4.57%)

After market: 0.7785 0 (-0.21%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to REE. REE was compared to 81 industry peers in the Automobile Components industry. REE has a bad profitability rating. Also its financial health evaluation is rather negative. REE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year REE has reported negative net income.
REE had a negative operating cash flow in the past year.
In the past 5 years REE always reported negative net income.
REE had a negative operating cash flow in each of the past 5 years.
REE Yearly Net Income VS EBIT VS OCF VS FCFREE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M -400M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of -85.78%, REE is doing worse than 97.53% of the companies in the same industry.
REE has a worse Return On Equity (-483.20%) than 91.36% of its industry peers.
Industry RankSector Rank
ROA -85.78%
ROE -483.2%
ROIC N/A
ROA(3y)-72.85%
ROA(5y)-105.85%
ROE(3y)-230.24%
ROE(5y)-208.07%
ROIC(3y)N/A
ROIC(5y)N/A
REE Yearly ROA, ROE, ROICREE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for REE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REE Yearly Profit, Operating, Gross MarginsREE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

More info and screens

3

2. Health

2.1 Basic Checks

REE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REE has more shares outstanding
REE has less shares outstanding than it did 5 years ago.
REE has a worse debt/assets ratio than last year.
REE Yearly Shares OutstandingREE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
REE Yearly Total Debt VS Total AssetsREE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

REE has an Altman-Z score of -11.63. This is a bad value and indicates that REE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of REE (-11.63) is worse than 96.30% of its industry peers.
A Debt/Equity ratio of 1.42 is on the high side and indicates that REE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.42, REE is not doing good in the industry: 86.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z -11.63
ROIC/WACCN/A
WACC4.4%
REE Yearly LT Debt VS Equity VS FCFREE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

REE has a Current Ratio of 2.28. This indicates that REE is financially healthy and has no problem in meeting its short term obligations.
REE has a better Current ratio (2.28) than 76.54% of its industry peers.
A Quick Ratio of 2.20 indicates that REE has no problem at all paying its short term obligations.
REE's Quick ratio of 2.20 is amongst the best of the industry. REE outperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.2
REE Yearly Current Assets VS Current LiabilitesREE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

REE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.69%, which is quite impressive.
Looking at the last year, REE shows a very negative growth in Revenue. The Revenue has decreased by -88.62% in the last year.
The Revenue for REE have been decreasing by -23.09% on average. This is quite bad
EPS 1Y (TTM)49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.6%
Revenue 1Y (TTM)-88.62%
Revenue growth 3Y163.52%
Revenue growth 5Y-23.09%
Sales Q2Q%-97.36%

3.2 Future

The Earnings Per Share is expected to decrease by -24.87% on average over the next years. This is quite bad
Based on estimates for the next years, REE will show a very strong growth in Revenue. The Revenue will grow by 402.68% on average per year.
EPS Next Y41.35%
EPS Next 2Y38.94%
EPS Next 3Y-24.87%
EPS Next 5YN/A
Revenue Next Year16240%
Revenue Next 2Y3952.58%
Revenue Next 3Y1204.14%
Revenue Next 5Y402.68%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
REE Yearly Revenue VS EstimatesREE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
REE Yearly EPS VS EstimatesREE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

REE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year REE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REE Price Earnings VS Forward Price EarningsREE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REE Per share dataREE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

A cheap valuation may be justified as REE's earnings are expected to decrease with -24.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.94%
EPS Next 3Y-24.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for REE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REE AUTOMOTIVE LTD - CLASS A

NASDAQ:REE (6/6/2025, 8:24:15 PM)

After market: 0.7785 0 (-0.21%)

0.7801

+0.03 (+4.57%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)09-24 2025-09-24/amc
Inst Owners32.38%
Inst Owner Change-59.04%
Ins Owners6.26%
Ins Owner Change0%
Market Cap24.20M
Analysts75
Price Target5.44 (597.35%)
Short Float %1.56%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.57%
Min EPS beat(2)-9.61%
Max EPS beat(2)18.76%
EPS beat(4)2
Avg EPS beat(4)6.07%
Min EPS beat(4)-21.17%
Max EPS beat(4)36.3%
EPS beat(8)4
Avg EPS beat(8)2.64%
EPS beat(12)8
Avg EPS beat(12)9.16%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.33%
PT rev (3m)-21.01%
EPS NQ rev (1m)2.87%
EPS NQ rev (3m)25.28%
EPS NY rev (1m)31.89%
EPS NY rev (3m)29.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 132.23
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-4.85
EYN/A
EPS(NY)-2.84
Fwd EYN/A
FCF(TTM)-2.47
FCFYN/A
OCF(TTM)-2.22
OCFYN/A
SpS0.01
BVpS0.75
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -85.78%
ROE -483.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-72.85%
ROA(5y)-105.85%
ROE(3y)-230.24%
ROE(5y)-208.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 236.68%
Cap/Sales 4115.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.2
Altman-Z -11.63
F-Score1
WACC4.4%
ROIC/WACCN/A
Cap/Depr(3y)353.7%
Cap/Depr(5y)383.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.6%
EPS Next Y41.35%
EPS Next 2Y38.94%
EPS Next 3Y-24.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-88.62%
Revenue growth 3Y163.52%
Revenue growth 5Y-23.09%
Sales Q2Q%-97.36%
Revenue Next Year16240%
Revenue Next 2Y3952.58%
Revenue Next 3Y1204.14%
Revenue Next 5Y402.68%
EBIT growth 1Y34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.17%
EBIT Next 3Y37.24%
EBIT Next 5Y26.01%
FCF growth 1Y17.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.73%
OCF growth 3YN/A
OCF growth 5YN/A